🇺🇸 FDA
Patent

US 11168128

Antibodies against SARS-CoV-2 and methods of using the same

granted A61KA61K2039/505A61P

Quick answer

US patent 11168128 (Antibodies against SARS-CoV-2 and methods of using the same) held by Vir Biotechnology, Inc. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vir Biotechnology, Inc.
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/505, A61P, A61P31/14